Lavvan
Closner has more than two decades of start-up, technology and health care experience. He was responsible for leading MedReleaf, which was the first ISO 9001 and GMP certified producer of cannabis in North America. MedReleaf was founded in 2013 and grew to be Canada’s most awarded licensed producer and was widely recognized for its scientific leadership, product innovation and its operational excellence. After completing the industry’s largest initial public offering in June 2017, MedReleaf was acquired for $2.5 billion in July 2018.
This person is not in any offices
Lavvan
LAVVAN produces a range of natural cannabinoid ingredients using its advanced cellular agriculture platform which supplies cannabinoids with unparalleled purity, consistency, potency and sustainability to serve a range of industries including health, beauty, food and beverage and pharmaceuticals.